ArticleVaccine2007

Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.

Sheila M Nolan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.